
Novo Medix Pharmaceutical Private Limited
Pharmaceutical company trading medical goods, incorporated in 2020 with office in West Bengal.
Pharmaceutical company trading medical goods, incorporated in 2020 with office in West Bengal.
Novo Medix Pharmaceutical Private Limited (NMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2020 (Five years and one month 27 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Aurobinda Banerjee, Abhijit Basu, Jyotirmoy Karmakar, and Two other members serve as directors at the Company.
Kolkata, West Bengal, India
+91-XXXXXXXXXX
-
U85100WB2020PTC235666
235666
Private Limited Indian Non-Government Company
03 Jan 2020
30 Sep 2023
31 Mar 2023
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhijit Basu ![]() | Managing Director | 03-Jan-2020 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aurobinda Banerjee ![]() | Whole-Time Director | 03-Jan-2020 | Current |
Jyotirmoy Karmakar ![]() | Whole-Time Director | 03-Jan-2020 | Current |
Sabir Hossain ![]() | Additional Director | 27-Dec-2022 | Current |
Khondaker Islam ![]() | Additional Director | 02-Aug-2021 | Current |
Novo Medix Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.68% decrease. The company also saw a substantial fall in profitability, with a 51.8% decrease in profit. The company's net worth Soared by an impressive increase of 83.86%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Novo Medix Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Aurobinda Banerjee is a mutual person
Aurobinda Banerjee, Abhijit Basu and 2 more are mutual person
There are no open charges registered against the company as per our records.
Novo Medix Pharmaceutical has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novo Medix Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Medix Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Novo Medix Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Novo Medix Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata.
Sabir Hossain was appointed as a Additional Director was appointed as a Additional Director on 27 Dec 2022 & has been associated with this company since 2 years 2 months .
Khondaker Nurul Islam was appointed as a Additional Director was appointed as a Additional Director on 02 Aug 2021 & has been associated with this company since 3 years 6 months .
Aurobinda Banerjee was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 03 Jan 2020 & has been associated with this company since 5 years 1 month .
Abhijit Basu was appointed as a Managing Director was appointed as a Managing Director on 03 Jan 2020 & has been associated with this company since 5 years 1 month .
Novo Medix Pharmaceutical Private Limited was incorporated on 03 Jan 2020.
The authorized share capital of Novo Medix Pharmaceutical Private Limited is ₹ 0.60 M and paid-up capital is ₹ 0.60 M.
Currently 5 directors are associated with Novo Medix Pharmaceutical Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Novo Medix Pharmaceutical Private Limited is 191 Debinibas Road Ground Floor P.O - Motijheel, P.S. Dumdum India, Kolkata, West Bengal, 700074.
The corporate identification number (CIN) of Novo Medix Pharmaceutical Private Limited is U85100WB2020PTC235666 and the company number is 235666 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Novo Medix Pharmaceutical Private Limited has fallen by -20.68%.
As Per 2023 financial reports, 20 employees are currently employed by Novo Medix Pharmaceutical Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Novo Medix Pharmaceutical Private Limited has experienced an upsurge of 83.86%.
The most recent Balance Sheet for Novo Medix Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2023.